argenx
Company ● Covered in 1 story + Follow ✴ AI Graph LinkedIn
This profile is built automatically from TLDRocket coverage.
Signals
1 story (new)
Media momentum
As of 10 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.
1 source
Source diversity
As of 10 Sep 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 10 Sep 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 10 Sep 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Aug 2026
Coverage span
As of 10 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.
Management
updated 6 Sep 2026- Tim Van Hauwermeiren CEO
- Peter Ulrichts Chief Scientific Officer
- Luc Truyen Chief Medical Officer
- Malini Moorthy General Counsel
- Sandrine Piret-Gerard Chief Commercialization Officer (CCO)
- Karl G. Chief Financial Officer
- David Knechtel Vice President And General Manager, UK & Ireland
- Karl Gubitz CFO
- Marc Schorpion Global Head of Human Resources
- Don deBethizy Director
- Steve Krognes Director
- Hans De Haard Advisor
+ 8 more tracked
Latest developments
2026
Relationships
Partnerships
- Chai Discovery partnered with this company · 1 source